IL197445A - Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole - Google Patents

Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole

Info

Publication number
IL197445A
IL197445A IL197445A IL19744509A IL197445A IL 197445 A IL197445 A IL 197445A IL 197445 A IL197445 A IL 197445A IL 19744509 A IL19744509 A IL 19744509A IL 197445 A IL197445 A IL 197445A
Authority
IL
Israel
Prior art keywords
processes
preparation
benzoic acids
oxadiazole benzoic
oxadiazole
Prior art date
Application number
IL197445A
Other languages
English (en)
Hebrew (he)
Other versions
IL197445A0 (en
Original Assignee
Ptc Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Inc filed Critical Ptc Therapeutics Inc
Publication of IL197445A0 publication Critical patent/IL197445A0/en
Publication of IL197445A publication Critical patent/IL197445A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL197445A 2006-09-08 2009-03-05 Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole IL197445A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84359506P 2006-09-08 2006-09-08
PCT/US2007/019561 WO2008030570A1 (en) 2006-09-08 2007-09-06 Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Publications (2)

Publication Number Publication Date
IL197445A0 IL197445A0 (en) 2009-12-24
IL197445A true IL197445A (en) 2014-01-30

Family

ID=38935880

Family Applications (1)

Application Number Title Priority Date Filing Date
IL197445A IL197445A (en) 2006-09-08 2009-03-05 Processes for the preparation of benzoic acids 1, 2, 4-oxadiazole

Country Status (24)

Country Link
US (2) US7678922B2 (enExample)
EP (1) EP2059513B1 (enExample)
JP (2) JP5955494B2 (enExample)
KR (1) KR101466368B1 (enExample)
CN (1) CN101535284B (enExample)
AR (3) AR062715A1 (enExample)
AU (1) AU2007292915B2 (enExample)
BR (1) BRPI0716996B8 (enExample)
CA (2) CA2662749C (enExample)
CL (1) CL2007002606A1 (enExample)
DK (1) DK2059513T3 (enExample)
ES (1) ES2404348T3 (enExample)
IL (1) IL197445A (enExample)
MX (1) MX2009002439A (enExample)
MY (1) MY148598A (enExample)
NZ (2) NZ598012A (enExample)
PE (2) PE20080771A1 (enExample)
PL (1) PL2059513T3 (enExample)
PT (1) PT2059513E (enExample)
RU (1) RU2495030C2 (enExample)
TW (1) TWI482761B (enExample)
UA (1) UA99265C2 (enExample)
WO (1) WO2008030570A1 (enExample)
ZA (1) ZA200901782B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2910551T3 (pl) 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
PT2402002T (pt) 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
CA2647903C (en) 2006-03-30 2016-12-13 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids
EP2068871B1 (en) 2006-09-25 2013-12-25 PTC Therapeutics, Inc. Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and the use for nonsense suppression
SI2076501T1 (sl) * 2006-09-25 2016-05-31 Ptc Therapeutics, Inc. Kristalinične oblike 3-(5-(2-florofenil)-1,2,4) oksadiazol-3-il)-benzojske kisline
ES2538359T3 (es) 2006-10-12 2015-06-19 Ptc Therapeutics, Inc. Métodos para administrar un 1,2,4-oxadiazol activo por vía oral para terapia de supresión de mutación sin sentido
CN101714009A (zh) * 2009-05-14 2010-05-26 翁印嵩 集成通用电话功能的计算机
ES2610362T3 (es) 2011-01-25 2017-04-27 Viviabiotech, S.L. Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1
UA114915C2 (uk) 2012-07-02 2017-08-28 Монсанто Текнолоджи Ллс Спосіб одержання 3,5-дизаміщених 1,2,4-оксадіазолів (варіанти)
TWI695717B (zh) 2014-03-06 2020-06-11 美商 Ptc 治療公司 １,２,４-二唑苯甲酸之鹽及醫藥組合物
CN105461650B (zh) * 2014-09-12 2018-04-13 杭州普晒医药科技有限公司 一种噁二唑化合物的溶剂化物及其制备方法
CN106316885B (zh) * 2015-07-03 2019-02-12 普济生物科技（台州）有限公司 一种3-[5-(2-氟苯基)-1,2,4-噁二唑-3-基]苯甲酸的制备方法
MX2018005361A (es) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.
TW201808922A (zh) 2016-06-20 2018-03-16 台灣神隆股份有限公司 製備阿塔魯仁及其中間體的方法
US12268669B2 (en) 2018-12-20 2025-04-08 Pfizer Inc. Pharmaceutical compositions and methods comprising a combination of a benzoxazole transthyretin stabilizer and an additional therapeutic agent
EA202192767A1 (ru) 2019-04-10 2021-12-29 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способ лечения опосредуемой нонсенс-мутацией мышечной дистрофии дюшенна у педиатрических пациентов
WO2022112919A1 (en) 2020-11-25 2022-06-02 Pfizer Inc. (aza)benzothiazolyl substituted pyrazole compounds
CN113045510B (zh) * 2021-03-31 2022-05-27 北京大学生命科学华东产业研究院 一种阿塔鲁伦的制备方法
CN114920667B (zh) * 2022-06-30 2024-06-21 湖南大学 一种阿塔鲁伦酯的电化学制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801509A1 (de) * 1978-01-12 1979-07-19 Schering Ag 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
DE3905242A1 (de) * 1989-02-21 1990-08-23 Basf Ag Verfahren zur herstellung von phenyloxdiazolylanilinen
NZ234760A (en) * 1989-08-18 1991-09-25 Sterling Drug Inc Antiviral oxazole compounds and compositions
DE4425794A1 (de) * 1994-07-21 1996-01-25 Basf Ag Nitrofarbstoffe
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CA2449544A1 (en) * 2001-06-08 2002-12-19 Cytovia, Inc. Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
MY151199A (en) * 2001-11-02 2014-04-30 Rigel Pharmaceuticals Inc Substituted diphenyl heterocycles useful for treating hcv infection
US20040132726A1 (en) * 2002-08-09 2004-07-08 Astrazeneca Ab And Nps Pharmaceuticals, Inc. New compounds
GB0303503D0 (en) 2003-02-14 2003-03-19 Novartis Ag Organic compounds
PL2910551T3 (pl) * 2003-04-11 2017-09-29 Ptc Therapeutics, Inc. Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
US20050075375A1 (en) * 2003-05-14 2005-04-07 Anadys Pharmaceuticals, Inc. Heterocyclic compounds for treating hepatitis C virus
PT2402002T (pt) * 2005-04-08 2018-10-08 Ptc Therapeutics Inc Composições de 1,2,4-oxadiazole oralmente activo para terapia de supressão de mutações nonsense
WO2008030570A1 (en) * 2006-09-08 2008-03-13 Ptc Therapeutics, Inc. Processes for the preparation of 1,2,4-oxadiazole benzoic acids

Also Published As

Publication number Publication date
PL2059513T3 (pl) 2013-06-28
WO2008030570A1 (en) 2008-03-13
UA99265C2 (ru) 2012-08-10
TWI482761B (zh) 2015-05-01
DK2059513T3 (da) 2013-05-06
ZA200901782B (en) 2010-06-30
AR062715A1 (es) 2008-11-26
CA2662749A1 (en) 2008-03-13
US8367841B2 (en) 2013-02-05
JP2010502715A (ja) 2010-01-28
CA2842625C (en) 2016-07-12
RU2495030C2 (ru) 2013-10-10
AR118922A2 (es) 2021-11-10
EP2059513B1 (en) 2013-01-23
EP2059513A1 (en) 2009-05-20
PT2059513E (pt) 2013-04-30
BRPI0716996A2 (pt) 2013-10-08
CA2842625A1 (en) 2008-03-13
AU2007292915A1 (en) 2008-03-13
TW200823180A (en) 2008-06-01
PE20080771A1 (es) 2008-06-13
ES2404348T3 (es) 2013-05-27
AU2007292915B2 (en) 2012-07-26
AR107474A2 (es) 2018-05-02
BRPI0716996B1 (pt) 2021-02-09
US20080139818A1 (en) 2008-06-12
NZ598012A (en) 2013-08-30
JP5955494B2 (ja) 2016-07-20
CL2007002606A1 (es) 2008-04-18
MY148598A (en) 2013-05-15
US7678922B2 (en) 2010-03-16
CN101535284A (zh) 2009-09-16
US20100063297A1 (en) 2010-03-11
KR101466368B1 (ko) 2014-11-27
MX2009002439A (es) 2009-03-27
HK1134094A1 (en) 2010-04-16
NZ575511A (en) 2012-02-24
RU2009113019A (ru) 2010-10-20
CA2662749C (en) 2015-01-20
PE20120669A1 (es) 2012-06-01
JP2014193896A (ja) 2014-10-09
CN101535284B (zh) 2014-12-10
BRPI0716996B8 (pt) 2021-05-25
KR20090054464A (ko) 2009-05-29
IL197445A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
IL197445A0 (en) Processes for the preparation of 1,2,4-oxadiazole benzoic acids
DK3872058T3 (en) Process for the preparation of 2,3,3,3 tetrahydrofluoropropene
PL1993985T3 (pl) Sposób wytwarzania 1,2-propanodiolu
IL202473A (en) Carboxylic acids are converted to benzoylamino-indene-2, their compounds and medical preparations containing these acids
IL195178A0 (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
IL195177A0 (en) 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
IL188330A0 (en) Processes for the preparation of
IL195176A0 (en) 4,5-diphenyl-pyrimidinyl substituted carboxylic acids, method for the production and use thereof as medicaments
SG10201508066VA (en) Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
IL226410A0 (en) Methods for the preparation of cycloalkylcarboxyamido-pyridine benzoic acids
ZA201008097B (en) Process for the preparation of 2,3,3,3-trifluoropropene
ZA200805006B (en) 1,3-Dioxane carboxylic acids
IL183379A0 (en) Processes for the preparation of linezolid intermediate
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
EP1922345A4 (en) PROCESS FOR THE PREPARATION OF COPOLYMER-1
IL190325A (en) A process for making loopfin
EP1996192A4 (en) PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4
IL199239A0 (en) Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-
ZA200601910B (en) Process for the preparation of organosilances
IL184592A0 (en) Process for the preparation of boronic acids and derivatives thereof
ZA200710665B (en) Processes for the preparation of paclitaxel
IL187824A0 (en) Processes for the preparation of paclitaxel
ZA201003264B (en) Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
IL196405A0 (en) Processes for the synthesus of o-desmethylvenlafaxine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed